文献速递临床试验与 GCP基础与转化研究

减少II型剖宫产瘢痕妊娠术中出血:高强度聚焦超声(HIFU)预处理与宫腔镜引导下吸宫术比较的研究方案——一项开放标签、1:1平行组、优效性设计、研究者发起的试验(IIT)

Reducing intraoperative hemorrhage in type II caesarean scar pregnancy: a study protocol comparing high-intensity focused ultrasound (HIFU) pretreatment vs. hysteroscopy-guided suction curettage-an open-label, 1:1 parallel-group, superiority-design investigator-initiated trial (IIT).
PubMed 文献 · Trials · 2025-08-06

该研究为一项开放标签、1:1平行组、优效性设计的研究者发起试验,计划纳入140例II型剖宫产瘢痕妊娠(CSP)患者,随机分为接受或未接受高强度聚焦超声(HIFU)预处理后行宫腔镜引导下吸宫术两组,主要结局为术中出血量,次要结局包括近出血发生率、治疗成功率及2年随访内的后续妊娠结局,旨在评估HIFU预处理联合宫腔镜引导下吸宫术的必要性。

要点

  • II型剖宫产瘢痕妊娠(CSP)治疗方案尚无共识,疾病异质性导致多种治疗选择并存。
  • HIFU作为无创预处理可能减少术中出血,但在低风险病例中可能过度使用。
  • 该试验计划纳入140例,随机1:1比较HIFU预处理联合宫腔镜引导下吸宫术与单纯宫腔镜引导下吸宫术。

核心结论

  • 该研究方案旨在评估HIFU预处理联合宫腔镜引导下吸宫术治疗II型CSP的必要性,以及单独宫腔镜手术与联合HIFU预处理方案的疗效比较。

研究设计与样本

  • 开放标签、1:1平行组、优效性设计的研究者发起试验,计划纳入140例参与者。
  • 所有参与者均接受宫腔镜引导下的手术吸宫术,随机分为接受或不接受HIFU预处理两组。
  • 干预前收集人口学特征、疾病特征、超声检查结果和实验室检查结果数据。

主要发现

  • 主要结局为术中出血量。
  • 次要结局包括近出血发生率、治疗成功率及2年随访期内的后续妊娠结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of caesarean scar pregnancy (CSP) has significantly increased due to the increasing prevalence of caesarean deliveries and advances in diagnostic imaging. However, no consensus has yet been reached on the optimal therapeutic approach. Type II CSP leads to disease heterogeneity, characterized by multiple treatment options and the absence of a unified therapeutic approach. Hysteroscopic treatment for CSP has demonstrated a notable success rate, particularly in cases of type I CSP. High-intensity focused ultrasound (HIFU) ablation has emerged as a novel, non-invasive treatment option that minimizes intraoperative blood loss. However, its use may be excessive in low-risk cases. Here, we report a protocol for a randomized clinical trial designed to evaluate the necessity of performing HIFU in CSP treatment when combined with suction curettage under hysteroscopic guidance. METHODS: We aim to propose a randomized clinical trial that will enroll 140 participants. All participants will undergo surgical suction curettage guided by hysteroscopy, randomized into groups with or without HIFU pretreatment. Data on demographic characteristics, disease characteristics, ultrasound findings, and laboratory test results will be collected before the intervention. The primary outcome will be the intraoperative blood loss. Secondary outcomes will include the incidence of near haemorrhage, therapeutic success rates, and subsequent pregnancy outcomes within a 2-year follow-up period. DISCUSSION: Hysteroscopy has exhibited favourable therapeutic outcomes in the management of CSP, though it remains associated with a risk of intraoperative haemorrhage. HIFU has shown promise as a preoperative adjuvant modality. However, the comparative clinical advantages of standalone hysteroscopic intervention versus HIFU-assisted protocols are insufficiently explored in prospective clinical studies. This investigation seeks to assess both the standalone efficacy of hysteroscopic resection and the efficacy of combined therapy incorporating HIFU pretreatment for type II CSP. TRIAL REGISTRATION: Registration number: ChiCTR2000034332. Registration date: 2nd July 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Sang C, Shi Q, Zhao L, et al. Reducing intraoperative hemorrhage in type II caesarean scar pregnancy: a study protocol comparing high-intensity focused ultrasound (HIFU) pretreatment vs. hysteroscopy-guided suction curettage-an open-label, 1:1 parallel-group, superiority-design investigator-initiated trial (IIT). Trials. 2025. PMID: 40770352. doi:10.1186/s13063-025-08967-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。